Cognition Therapeutics Statistics

Total Valuation

CGTX has a market cap or net worth of $96.95 million. The enterprise value is $65.69 million.

Market Cap	96.95M
Enterprise Value	65.69M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

CGTX has 89.35 million shares outstanding. The number of shares has increased by 70.27% in one year.

Current Share Class	89.35M
Shares Outstanding	89.35M
Shares Change (YoY)	+70.27%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	1.17%
Owned by Institutions (%)	17.09%
Float	82.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.96
P/TBV Ratio	2.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,295.46

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-112.00%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	14.14%
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +235.18% in the last 52 weeks. The beta is 1.81, so CGTX's price volatility has been higher than the market average.

Beta (5Y)	1.81
52-Week Price Change	+235.18%
50-Day Moving Average	1.09
200-Day Moving Average	1.43
Relative Strength Index (RSI)	43.63
Average Volume (20 Days)	978,752

Short Selling Information

The latest short interest is 7.98 million, so 8.93% of the outstanding shares have been sold short.

Short Interest	7.98M
Short Previous Month	7.32M
Short % of Shares Out	8.93%
Short % of Float	9.70%
Short Ratio (days to cover)	5.71

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.84M
Pretax Income	-19.58M
Net Income	-19.58M
EBITDA	-42.82M
EBIT	-42.84M
Earnings Per Share (EPS)	-$0.25

Full Income Statement

Balance Sheet

The company has $36.81 million in cash and $638,000 in debt, with a net cash position of $36.17 million or $0.40 per share.

Cash & Cash Equivalents	36.81M
Total Debt	638,000
Net Cash	36.17M
Net Cash Per Share	$0.40
Equity (Book Value)	34.27M
Book Value Per Share	0.39
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	18,250
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-70.27%
Shareholder Yield	-70.27%
Earnings Yield	-19.22%
FCF Yield	n/a

Analyst Forecast

The average price target for CGTX is $3.50, which is 222.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.50
Price Target Difference	222.58%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a